Evans John M. 的 Form 4/A 修正申報
修正Beam Therapeutics Inc.（BEAM），2022/2/2 申報
- 申報編號
- 0000899243-22-004197
- 申報時間
- 2022/2/2
- 交易日
- 2021/11/16-2022/1/31
- 申報延遲
- 78 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2021/7/7
這份申報列了 14 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $334.2 萬。交易後 78 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Evans John M.CIK 0001786304 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/11/16 | Common Stock | G贈與處分 | −12,000 | $0.00 | $0 | 968,825 | 直接 | |
| 2022/1/31 | Common Stock | S賣出處分 | −801 | $63.79F3 | −$51,095.79 | 968,024 | 直接 | |
| 2022/1/31 | Common Stock | S賣出處分 | −2,172 | $64.47F4 | −$140,028.84 | 965,852 | 直接 | |
| 2022/1/31 | Common Stock | S賣出處分 | −3,177 | $65.49F5 | −$208,061.73 | 962,675 | 直接 | |
| 2022/1/31 | Common Stock | S賣出處分 | −6,337 | $66.55F6 | −$421,727.35 | 956,338 | 直接 | |
| 2022/1/31 | Common Stock | S賣出處分 | −13,535 | $67.44F7 | −$912,800.4 | 942,803 | 直接 | |
| 2022/1/31 | Common Stock | S賣出處分 | −3,978 | $68.15F8 | −$271,100.7 | 938,825 | 直接 | |
| 2022/1/31 | Common Stock | M行使選擇權取得 | +100,000 | $1.03 | +$103,000 | 1,038,825 | 直接 | |
| 2022/1/31 | Common Stock | S賣出處分 | −300 | $63.45F9 | −$19,035 | 182,700 | 間接 | |
| 2022/1/31 | Common Stock | S賣出處分 | −1,615 | $64.46F10 | −$104,102.9 | 181,085 | 間接 | |
| 2022/1/31 | Common Stock | S賣出處分 | −1,900 | $65.55F11 | −$124,545 | 179,185 | 間接 | |
| 2022/1/31 | Common Stock | S賣出處分 | −4,105 | $66.48F12 | −$272,900.4 | 175,080 | 間接 | |
| 2022/1/31 | Common Stock | S賣出處分 | −9,408 | $67.43F13 | −$634,381.44 | 165,672 | 間接 | |
| 2022/1/31 | Common Stock | S賣出處分 | −2,672 | $68.16F14 | −$182,123.52 | 163,000 | 間接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/1/31 | Common Stock | M行使選擇權處分 | −100,000 | $0.00 | $0 | 284,345 | 直接 | |
| 2022/1/31 | Common Stock | A公司授予取得 | +112,500 | $0.00 | $0 | 112,500 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
On each of July 7, 2021 and October 6, 2021, the reporting person filed a Form 4 which inadvertently reported an exercise of stock options in connection with certain sales of common stock. In fact, the reporting person did not exercise any stock options in connection with the sales reported on such Forms 4. Accordingly, the first line of each of Tables 1 and 2 of this Form 4 reflects the corrected number of securities beneficially owned by the reporting person prior to the transactions reported herein.
- F2
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The reporting person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $63.60 to $63.96, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.21 to $64.50, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.20 to $65.99, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.09 to $66.94, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.00 to $67.99, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $68.00 to $68.60, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $63.26 to $63.58, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.17 to $64.50, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F11
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.20 to $65.99, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F12
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.00 to $66.94, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F13
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.00 to $67.99, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F14
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $68.00 to $68.60, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F15
The option vests as to 25% on the first anniversary of the of the vesting commencement date, January 8, 2018, and at a rate of 2.78% each month thereafter until the option is fully vested.
- F16
The option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the reporting person's continued service with BEAM through each vesting date.